DK0381584T3 - Use of certain gamma interferons for the treatment of ovarian cancer - Google Patents

Use of certain gamma interferons for the treatment of ovarian cancer

Info

Publication number
DK0381584T3
DK0381584T3 DK90400266.4T DK90400266T DK0381584T3 DK 0381584 T3 DK0381584 T3 DK 0381584T3 DK 90400266 T DK90400266 T DK 90400266T DK 0381584 T3 DK0381584 T3 DK 0381584T3
Authority
DK
Denmark
Prior art keywords
ovarian cancer
treatment
gamma interferons
certain gamma
certain
Prior art date
Application number
DK90400266.4T
Other languages
Danish (da)
Inventor
Danielle Lando
Maud Brandely
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378406&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0381584(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK0381584T3 publication Critical patent/DK0381584T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Use of a recombinant polypeptide having an activity of the human gamma-interferon type for preparing a pharmaceutical composition which can be administered intraperitoneally in perfusion and is intended for the effective treatment of ovarian cancer.
DK90400266.4T 1989-02-02 1990-02-01 Use of certain gamma interferons for the treatment of ovarian cancer DK0381584T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8901346A FR2644067B1 (en) 1989-02-02 1989-02-02 USE OF CERTAIN GAMMA INTERFERONS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OVARY CANCER BY THE INTRAPERITONEAL ROUTE

Publications (1)

Publication Number Publication Date
DK0381584T3 true DK0381584T3 (en) 1994-02-14

Family

ID=9378406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90400266.4T DK0381584T3 (en) 1989-02-02 1990-02-01 Use of certain gamma interferons for the treatment of ovarian cancer

Country Status (12)

Country Link
EP (1) EP0381584B1 (en)
JP (1) JPH0772137B2 (en)
KR (1) KR100203316B1 (en)
AT (1) ATE99954T1 (en)
AU (1) AU632528B2 (en)
CA (1) CA2009106A1 (en)
DE (1) DE69005837T2 (en)
DK (1) DK0381584T3 (en)
FR (1) FR2644067B1 (en)
HU (1) HU204711B (en)
OA (1) OA09191A (en)
ZA (1) ZA90671B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
EP0302862A1 (en) * 1986-03-17 1989-02-15 Schering Corporation Treatment of cancers with gamma interferon

Also Published As

Publication number Publication date
OA09191A (en) 1992-06-30
HUT54302A (en) 1991-02-28
KR900012628A (en) 1990-09-01
EP0381584A2 (en) 1990-08-08
JPH02235818A (en) 1990-09-18
DE69005837D1 (en) 1994-02-24
HU204711B (en) 1992-02-28
FR2644067A1 (en) 1990-09-14
EP0381584A3 (en) 1991-11-06
ATE99954T1 (en) 1994-01-15
AU4895390A (en) 1990-08-09
JPH0772137B2 (en) 1995-08-02
CA2009106A1 (en) 1990-08-02
HU900202D0 (en) 1990-03-28
AU632528B2 (en) 1993-01-07
KR100203316B1 (en) 1999-06-15
ZA90671B (en) 1991-04-24
EP0381584B1 (en) 1994-01-12
FR2644067B1 (en) 1993-02-05
DE69005837T2 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
ZA886471B (en) Conjugates of cytokines with imunologulins
DK0911033T4 (en) Use of consensus interferon to reduce the side effects of interferon therapy in viral hepatitis
DE3650790D1 (en) Human Interferon Beta 2A for use as a medicament
DE68909267D1 (en) Drug for the treatment of fibrotic disorder and antifibrotic compound.
DE3773295D1 (en) HOMOGENEOUS RECOMBINANT IMMUNE INTERFERON FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DK0381584T3 (en) Use of certain gamma interferons for the treatment of ovarian cancer
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
DK264787A (en) APPLICATION OF HUMANT ALFA INTERFERON FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
ATE92333T1 (en) MEDICATIONS FOR THE INTRALESION TREATMENT OF SCALP-LIKE CELL CARCINOMA WITH RECOMBINANT HUMAN ALPHA INTERFERON.
ATE74517T1 (en) TREATMENT OF SOME LEUKEMIAS WITH A COMPOSITION OF INTERFERON-GAMMA AND INTERFERON-ALPHA.
DE3777224D1 (en) USE OF INTERFERON BETA AND INTERLEUKIN-2 IN COMBINATION THERAPY AND COMPOSITIONS THEREOF.
DK0427633T3 (en) Use of a polypeptide with gamma interferon activity for the preparation of pharmaceutical preparations intended for the treatment of primitive pleural cancer
ATE65404T1 (en) COMPOSITIONS AND USE OF INTERLEUKIN-2 AND/OR INTERFERON-BETA AND THE TUMOR NECROSIS FACTOR FOR COMBINATION THERAPY OR FOR THE MANUFACTURE OF PHARMACEUTICALS OR FORMULATIONS.
ATE73346T1 (en) USE OF INTERFERON-BETA AND INTERLEUKIN-2 IN COMBINATION THERAPY AND COMPOSITIONS THEREOF.